{"gene":"DTX3L","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2003,"finding":"DTX3L (BBAP) functions as an E3 ubiquitin ligase, demonstrated by self-ubiquitination activity; DTX family members homodimerize and heterodimerize in vivo, with BBAP and DTX1 associating via their unique N termini to enhance self-ubiquitination.","method":"In vitro self-ubiquitination assay, co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro E3 ligase assay with mutagenesis context, replicated in subsequent studies","pmids":["12670957"],"is_preprint":false},{"year":2006,"finding":"BBAP (DTX3L) regulates the subcellular localization of BAL1 (PARP9) through a dynamic shuttling mechanism, and both are regulated by a IFN-γ-responsive bidirectional promoter on chromosome 3q21.","method":"Immunofluorescence localization, reporter assay, co-expression studies","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct localization experiment with functional consequence, single lab","pmids":["16809771"],"is_preprint":false},{"year":2009,"finding":"BBAP (DTX3L) selectively monoubiquitylates histone H4 at lysine 91, and disruption of this activity is associated with loss of chromatin-associated H4K20 methylase, reduction in mono- and dimethyl H4K20, and delayed 53BP1 foci formation at DNA damage sites.","method":"In vitro ubiquitylation assay, site-directed mutagenesis, immunofluorescence of 53BP1 foci","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro assay with mutagenesis, multiple orthogonal readouts, replicated by other labs","pmids":["19818714"],"is_preprint":false},{"year":2012,"finding":"BAL1 (PARP9) is recruited to PARP1-PARylated DNA damage sites via its macrodomains in a PAR-dependent manner, and its partner DTX3L (BBAP) mediates local ubiquitylation that promotes subsequent BRCA1 and 53BP1 recruitment, functioning independently of ATM, MDC1, and RNF8.","method":"Genetic epistasis (ATM/MDC1/RNF8 knockouts), live-cell imaging, co-immunoprecipitation, PAR-binding assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — epistasis with multiple DDR pathway components, reconstitution of recruitment, multiple orthogonal methods","pmids":["23230272"],"is_preprint":false},{"year":2014,"finding":"DTX3L forms a complex with ARTD8 (PARP14) and ARTD9 (PARP9), and together these complexes repress IRF1 expression; DTX3L together with STAT1 and STAT3 mediates cell migration; ARTD8 enzymatic activity is required for survival in metastatic prostate cancer cells.","method":"Co-immunoprecipitation, siRNA knockdown with proliferation/survival/migration assays, Western blot","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2-3 — reciprocal Co-IP with functional KD phenotype, single lab","pmids":["24886089"],"is_preprint":false},{"year":2015,"finding":"PARP9-DTX3L complex interacts with STAT1 and acts as an E3 ubiquitin ligase targeting host histone H2BJ to promote interferon-stimulated gene expression, and also targets viral 3C proteases for degradation via the immunoproteasome.","method":"Co-immunoprecipitation, transgenic mouse model, ubiquitin ligase assay, antiviral infection assay","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 — in vivo and in vitro mechanistic validation with multiple substrates, replicated by other labs","pmids":["26479788"],"is_preprint":false},{"year":2015,"finding":"DTX3L depletion in melanoma cells decreases FAK/PI3K/AKT signaling activity but not MEK/ERK signaling, and reduces invasion and metastasis, establishing FAK/PI3K/AKT as the pathway through which DTX3L mediates melanoma metastasis.","method":"siRNA knockdown, invasion/metastasis assays, Western blot of signaling intermediates","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2-3 — KD with defined pathway readout, single lab","pmids":["26033450"],"is_preprint":false},{"year":2015,"finding":"HDAC1,2 inhibition increases H4K91 acetylation, which competitively reduces BBAP (DTX3L)-mediated H4K91 monoubiquitination and impairs BBAP-dependent DSB repair.","method":"Small molecule inhibition, histone modification ChIP/Western blot, DSB repair assay","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic link between competing PTMs on H4K91 and repair, single lab","pmids":["25605023"],"is_preprint":false},{"year":2016,"finding":"BBAP (DTX3L) translocates from the cytoplasm to the nucleus upon paclitaxel treatment in vemurafenib-resistant melanoma cells, and this translocation decreases metastatic ability via downregulation of phospho-FAK and N-cadherin and upregulation of p21 and E-cadherin.","method":"Immunofluorescence, subcellular fractionation, invasion/migration assays","journal":"Molecular medicine reports","confidence":"Low","confidence_rationale":"Tier 3 — localization experiment with phenotypic consequence but limited mechanistic follow-up, single lab","pmids":["27922665"],"is_preprint":false},{"year":2017,"finding":"DTX3L (PARP9/Dtx3L heterodimer) mediates NAD+-dependent mono-ADP-ribosylation of the carboxyl group of ubiquitin Gly76, exclusively in the context of ubiquitin processing by E1 and E2 enzymes; this ADP-ribosylation precludes substrate ubiquitylation. Poly(ADP-ribose) binding to PARP9 macrodomains increases E3 activity, while NAD+ restrains it.","method":"In vitro ADP-ribosylation assay, mutagenesis of NAD+ binding site, mass spectrometry, biochemical reconstitution","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis, mass spectrometry validation, multiple orthogonal methods","pmids":["28525742"],"is_preprint":false},{"year":2020,"finding":"DTX3L and ARTD9 (PARP9) associate with STAT1 under TNF-α stimulation in fibroblast-like synoviocytes and modulate STAT1 nuclear localization and transcriptional activity, promoting expression of MMP-9 and IL-6.","method":"Co-immunoprecipitation, immunofluorescence, siRNA knockdown, Western blot","journal":"Tissue & cell","confidence":"Low","confidence_rationale":"Tier 3 — single Co-IP with localization data, single lab, limited mechanistic depth","pmids":["32473705"],"is_preprint":false},{"year":2021,"finding":"IFN signaling induces PARP9/DTX3L-dependent ADP-ribosylation of host proteins, and the SARS-CoV-2 Nsp3 macrodomain reverses this modification; however, deletion of PARP9 or DTX3L does not impair IFN signaling or induction of IFN-responsive genes, indicating ADP-ribosylation is a downstream effector rather than a signaling regulator.","method":"Immunofluorescence-based ADP-ribosylation assay, CRISPR knockout of PARP9/DTX3L, ectopic Nsp3 expression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — genetic KO with multiple functional readouts, replicated in parallel study","pmids":["34358560"],"is_preprint":false},{"year":2022,"finding":"The DTX3L D3 domain (residues 230-510) mediates interaction with PARP9 with nanomolar affinity and 1:1 stoichiometry; the N-terminal region (1-200) mediates higher-order oligomerization; ADP-ribosylation of ubiquitin Gly76 is reversible in vitro by macrodomain-type hydrolases.","method":"Recombinant protein reconstitution, binding affinity measurement, size-exclusion chromatography, in vitro deribosylation assay","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with domain mapping, quantitative binding measurements, multiple orthogonal approaches","pmids":["35037691"],"is_preprint":false},{"year":2023,"finding":"DTX3L rapidly co-localizes with p53 at PARP1-PARylated DNA damage sites, polyubiquitylates p53 on its lysine-rich C-terminal domain, and targets p53 for proteasomal degradation; DTX3L knockout significantly increases and prolongs p53 retention at damage sites.","method":"Co-immunoprecipitation, ubiquitylation assay, live-cell imaging, CRISPR knockout","journal":"iScience","confidence":"High","confidence_rationale":"Tier 1-2 — KO with direct substrate ubiquitylation demonstrated and spatial-temporal imaging","pmids":["37096048"],"is_preprint":false},{"year":2023,"finding":"DTX3L ubiquitinates TBK1 at K30 and K401 via K63-linked ubiquitination, and binds SRC tyrosine kinase to mediate TBK1 phosphorylation, establishing an IFN-β-ETS1-DTX3L-TBK1 positive-feedback loop.","method":"Co-immunoprecipitation, site-directed mutagenesis of ubiquitination sites, kinase phosphorylation assay","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis of substrate sites with functional readout, single lab","pmids":["37255478"],"is_preprint":false},{"year":2023,"finding":"DTX3L ubiquitinates NLRP3 via interaction between the NLRP3 LRR domain and the DTX3L RING domain, resulting in NLRP3 degradation and regulation of pyroptosis.","method":"Co-immunoprecipitation, mass spectrometry, domain mapping, ubiquitylation assay, LDH/cell death assays","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Medium","confidence_rationale":"Tier 2-3 — domain-level interaction mapping with functional pyroptosis readout, single lab","pmids":["36706922"],"is_preprint":false},{"year":2023,"finding":"Dual ADP-ribosylation of closely spaced cysteines on the androgen receptor (AR) by PARP7 mediates recognition by the DTX3L/PARP9 complex with high affinity (Kd = 80.5 nM); oligomerization of the DTX3L/PARP9 complex is required for efficient ADP-ribosyl-peptide interaction.","method":"Synthetic peptide binding assay, fluorescence-based affinity measurement, deletion mutagenesis of oligomerization domain","journal":"ACS chemical biology","confidence":"High","confidence_rationale":"Tier 1 — quantitative binding with synthetic substrates and mutagenesis, multiple orthogonal methods","pmids":["37939374"],"is_preprint":false},{"year":2023,"finding":"DTX3L mediates ubiquitination and degradation of cGAS in pancreatic cancer cells, suppressing cGAS-STING pathway activation and antitumor immunity.","method":"Co-immunoprecipitation, ubiquitylation assay, siRNA knockdown with STING pathway readout","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 — substrate ubiquitylation with pathway functional consequence, single lab","pmids":["37774567"],"is_preprint":false},{"year":2024,"finding":"Crystal structure of the DTX3L N-terminal D2 domain reveals a tetramer with D2 symmetry and two interfaces; D1-D2 domains mediate homo-oligomerization and are dispensable for PARP9 heterodimerization but required for assembling the high-molecular-weight oligomeric complex with efficient reader function for ADP-ribosylated androgen receptor.","method":"X-ray crystallography, native mass spectrometry, DTX3L-KO cell reconstitution with deletion mutants, ADP-ribose reader assay","journal":"Protein science","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional validation by mutagenesis and cell reconstitution","pmids":["38511494"],"is_preprint":false},{"year":2024,"finding":"PARP14 is the major enzyme responsible for IFN-induced ADP-ribosylation; PARP9/DTX3L complex regulates PARP14 protein levels post-translationally and both localize to IFNγ-induced cytoplasmic inclusions; PARP14 ADP-ribosylates itself and DTX3L; PARP9 macrodomain 1 hydrolyzes PARP14 activity product.","method":"CRISPR knockout, immunofluorescence, mass spectrometry, in vitro ADP-ribosylation assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — genetic KO with multiple orthogonal methods, parallel replication in companion paper","pmids":["38834853"],"is_preprint":false},{"year":2024,"finding":"PARP9/DTX3L complex is required to uphold PARP14 protein levels via post-translational mechanisms; KH-like domains in PARP9, DTX3L, and PARP14 coordinate protein-protein interactions; DTX3L interaction with PARP14 in vitro suppresses PARP14 auto-ADP-ribosylation and promotes trans-ADP-ribosylation of PARP9 and DTX3L; DTX3L homodimerization is coordinated by a KH-like domain.","method":"In vitro ADP-ribosylation assay, domain mutagenesis, co-immunoprecipitation, cell survival assay with truncation mutants","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro assay with domain mutagenesis plus cellular rescue experiments, companion study replication","pmids":["38182103"],"is_preprint":false},{"year":2024,"finding":"DTX3L ubiquitylates single-stranded DNA and RNA (and double-stranded DNA with ≥2 nt 3' overhang) via ester bond formation at the 3'-terminal adenosine; the minimal catalytic fragment comprises the C-terminal RING and DTC domains; NMR analysis shows the DTC domain binds single-stranded DNA and facilitates Ub transfer from RING-bound E2-conjugated Ub; this modification is reversibly cleaved by deubiquitinases including USP2, JOSD1, and SARS-CoV-2 PLpro.","method":"In vitro ubiquitylation assay, NMR, domain deletion mutagenesis, deubiquitinase cleavage assay","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with NMR structural validation and mutagenesis, multiple DUBs tested","pmids":["39377462"],"is_preprint":false},{"year":2024,"finding":"DTX3L ubiquitylates DNA and RNA in vitro via ester bond formation; this activity is shared with DTX3 but not DTX1, DTX2, or DTX4; DTX3L shows preference for 3'-terminal adenosine; ubiquitylation of nucleic acids is reversible by USP2, JOSD1, and SARS-CoV-2 PLpro.","method":"In vitro ubiquitylation assay with purified proteins and synthetic substrates, parallel testing of all DELTEX family members","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with substrate specificity mapping across family members, replicated in parallel study","pmids":["39242775"],"is_preprint":false},{"year":2024,"finding":"DTX3L ubiquitinates TIRR at lysine 187, facilitating XPO1-mediated TIRR nuclear export and proteasomal degradation after DNA damage; this displaces TIRR from 53BP1, impairing NHEJ and causing HR deficiency and PARP inhibitor sensitivity.","method":"Co-immunoprecipitation, site-directed mutagenesis (K187), nuclear export inhibition, PARP inhibitor sensitivity assay, chromosomal instability assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — specific ubiquitylation site identified with mutagenesis, functional consequence in multiple assays, clinical correlation","pmids":["39632881"],"is_preprint":false},{"year":2025,"finding":"DTX3L ubiquitinates USP28, leading to its proteasomal degradation, while USP28 counteracts by deubiquitinating both itself and DTX3L; this mutual regulation fine-tunes DSB repair across NHEJ, HR, SSA, and MMEJ pathways.","method":"Ubiquitylation assay, deubiquitylation assay, DSB repair pathway reporter assays, double knockdown rescue","journal":"iScience","confidence":"High","confidence_rationale":"Tier 1-2 — reciprocal enzymatic activities demonstrated in vitro with functional rescue in multiple repair pathways","pmids":["40703443"],"is_preprint":false},{"year":2023,"finding":"DTX3L binds EGFR and prevents its ubiquitination-mediated degradation, thereby activating the FAK/PI3K/Akt pathway to promote pancreatic cancer progression.","method":"Co-immunoprecipitation, ubiquitylation assay, orthotopic tumor model, proliferation/invasion assays","journal":"Biochemical genetics","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP with substrate ubiquitylation and in vivo tumor model, single lab","pmids":["37460862"],"is_preprint":false},{"year":2026,"finding":"DTX3L directly interacts with and ubiquitinates SNAI1 (SNAIL), a master EMT regulator, leading to GSK-3β-dependent proteasomal degradation of SNAI1; loss of DTX3L stabilizes SNAI1 and enhances EMT and stem-like phenotypes in gastric cancer.","method":"Co-immunoprecipitation, ubiquitylation assay, cell line/organoid/animal model, TGF-β1/miR-135b-5p regulatory axis characterization","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 — substrate ubiquitylation shown with multiple model systems, single lab","pmids":["41972409"],"is_preprint":false},{"year":2026,"finding":"USP10 and DTX3L regulate SATB2 ubiquitination at K266 in glioma stem cells through mutually exclusive interactions and opposing activities; DTX3L acts as a ubiquitin ligase for SATB2, promoting its degradation.","method":"Co-immunoprecipitation, ubiquitylation assay, site-directed mutagenesis (K266), GSC self-renewal assay, in vivo tumor model","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 — specific ubiquitylation site identified with mutagenesis, functional rescue, single lab","pmids":["41507172"],"is_preprint":false},{"year":2026,"finding":"DTX3L binds PKCα through its RING domain and targets PKCα for K48-linked ubiquitination and proteasomal degradation, attenuating p38 MAPK phosphorylation to drive breast cancer progression.","method":"Co-immunoprecipitation, domain mapping, ubiquitylation assay, transcriptomics after KD, kinase phosphorylation assay","journal":"International journal of biological macromolecules","confidence":"Medium","confidence_rationale":"Tier 2 — domain-level interaction with K48-linkage specificity and pathway functional readout, single lab","pmids":["41679478"],"is_preprint":false},{"year":2025,"finding":"DTX3L promotes renal cell carcinoma progression by ubiquitinating and degrading the Hippo pathway tumor suppressor LATS2.","method":"Proteomic screening, co-immunoprecipitation, ubiquitylation assay, in vitro and in vivo tumor growth assays","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2-3 — substrate identified by proteomics and validated by Co-IP/ubiquitylation with in vivo model, single lab","pmids":["41203184"],"is_preprint":false}],"current_model":"DTX3L is a multi-domain RING-type E3 ubiquitin ligase that heterodimerizes with PARP9 (via its D3 domain) and homo-oligomerizes (via D1/D2 domains) to form a complex with dual enzymatic activities: it ubiquitylates protein substrates (including histone H4K91, p53, TIRR, TBK1, NLRP3, cGAS, SNAI1, SATB2, LATS2, PKCα, and USP28) and, together with PARP9, mediates NAD+-dependent mono-ADP-ribosylation of ubiquitin Gly76 to restrain ubiquitylation; the complex also reads PARP7-generated ADP-ribosylation marks on substrates such as the androgen receptor, regulates PARP14 protein levels and activity through protein-protein interaction, and uniquely ubiquitylates single-stranded DNA and RNA via its RING-DTC domains, with all these activities critically linked to interferon signaling, DNA damage response pathway choice, and cancer progression."},"narrative":{"teleology":[{"year":2003,"claim":"Establishing that DTX3L possesses intrinsic E3 ubiquitin ligase activity and that Deltex family members homo- and heterodimerize resolved the basic enzymatic identity of this previously uncharacterized protein.","evidence":"In vitro self-ubiquitination assay and co-immunoprecipitation of DTX family members","pmids":["12670957"],"confidence":"High","gaps":["No physiological substrate identified","Dimerization interface unmapped","No cellular function established"]},{"year":2006,"claim":"Demonstrating that DTX3L and PARP9 are co-regulated by an IFN-γ-responsive bidirectional promoter and that DTX3L controls PARP9 subcellular localization linked the E3 ligase to interferon biology and established the obligate functional partnership.","evidence":"Immunofluorescence, reporter assays, and co-expression studies","pmids":["16809771"],"confidence":"Medium","gaps":["Whether DTX3L directly binds PARP9 was not demonstrated biochemically","Functional consequence of relocalization unclear"]},{"year":2009,"claim":"Identification of histone H4K91 as the first physiological substrate connected DTX3L to chromatin biology and the DNA damage response, showing that H4K91 monoubiquitylation supports H4K20 methylation and 53BP1 focus formation.","evidence":"In vitro ubiquitylation assay with site-directed mutagenesis and 53BP1 foci immunofluorescence","pmids":["19818714"],"confidence":"High","gaps":["Whether H4K91ub is direct trigger or permissive mark for H4K20me was unresolved","Competition with H4K91 acetylation not yet tested"]},{"year":2012,"claim":"Showing that PARP9 recruits DTX3L to PARylated DNA damage sites independently of ATM/MDC1/RNF8 established a parallel ubiquitin-dependent DDR pathway that promotes BRCA1 and 53BP1 recruitment.","evidence":"Genetic epistasis in ATM/MDC1/RNF8 knockouts with live-cell imaging and PAR-binding assays","pmids":["23230272"],"confidence":"High","gaps":["Substrates ubiquitylated at damage sites beyond H4 were unknown","Relative contribution to repair pathway choice unresolved"]},{"year":2015,"claim":"Expanding DTX3L substrates to include host histone H2BJ and viral 3C proteases, and showing STAT1-dependent ISG regulation, established the PARP9-DTX3L complex as a bona fide innate immune effector targeting both host chromatin and viral proteins for degradation.","evidence":"Co-immunoprecipitation, ubiquitin ligase assay, transgenic mouse model, antiviral infection assay","pmids":["26479788"],"confidence":"High","gaps":["Breadth of viral substrates unknown","Whether ubiquitylation is K48- or K63-linked on these substrates was not specified"]},{"year":2015,"claim":"Linking DTX3L to FAK/PI3K/AKT signaling in melanoma invasion and showing that acetylation at H4K91 competes with DTX3L-mediated ubiquitylation extended the functional scope to cancer metastasis and PTM crosstalk.","evidence":"siRNA knockdown with signaling readouts in melanoma; HDAC inhibitor treatment with DSB repair assays","pmids":["26033450","25605023"],"confidence":"Medium","gaps":["Direct ubiquitylation targets in FAK pathway not identified","Whether H4K91 PTM competition occurs genome-wide or at damage sites specifically was unresolved"]},{"year":2017,"claim":"Discovering that the PARP9-DTX3L complex mono-ADP-ribosylates ubiquitin at Gly76 in an NAD⁺-dependent manner—precluding substrate ubiquitylation—revealed a fundamentally new enzymatic activity coupling ADP-ribosylation to ubiquitin regulation.","evidence":"In vitro reconstitution with mass spectrometry, mutagenesis of NAD⁺ binding site","pmids":["28525742"],"confidence":"High","gaps":["Which active site catalyzes the ADP-ribosylation was debated","In vivo substrates of ADPr-Ub not identified","Reversibility mechanism unknown"]},{"year":2022,"claim":"Mapping the D3 domain as the nanomolar-affinity PARP9-binding interface and showing that N-terminal D1/D2 domains drive oligomerization, while demonstrating reversibility of Ub-Gly76 ADP-ribosylation by macrodomain hydrolases, provided the structural logic for the complex.","evidence":"Recombinant reconstitution, quantitative binding measurements, size-exclusion chromatography, in vitro deribosylation","pmids":["35037691"],"confidence":"High","gaps":["No high-resolution structure of the full heterodimer","Oligomerization stoichiometry in cells uncertain"]},{"year":2023,"claim":"Identifying p53, TBK1, NLRP3, and cGAS as DTX3L ubiquitylation substrates broadened the functional repertoire to encompass tumor suppressor turnover at damage sites, innate immune signaling via TBK1-IFN-β positive feedback, inflammasome regulation, and cGAS-STING suppression in cancer.","evidence":"Co-IP, site-directed mutagenesis of ubiquitylation sites, CRISPR KO with live-cell imaging (p53); ubiquitylation assays with pathway readouts (TBK1, NLRP3, cGAS)","pmids":["37096048","37255478","36706922","37774567"],"confidence":"High","gaps":["Whether all substrates require PARP9 co-factor is unclear","Linkage type specificity for each substrate incompletely characterized"]},{"year":2023,"claim":"Demonstrating that PARP7-mediated dual ADP-ribosylation of closely spaced cysteines on the androgen receptor is read by the oligomeric DTX3L/PARP9 complex with nanomolar affinity established a 'writer-reader' paradigm for ADP-ribosylation signaling.","evidence":"Synthetic ADP-ribosylated peptide binding assay, fluorescence affinity measurement, oligomerization domain deletion mutagenesis","pmids":["37939374"],"confidence":"High","gaps":["Downstream functional consequence of AR reading is unknown","Whether other ADP-ribosylated substrates are similarly read is untested"]},{"year":2024,"claim":"Crystal structure of the D2 domain tetramer and functional reconstitution showed that D1-D2-mediated oligomerization is dispensable for PARP9 binding but essential for assembling the high-molecular-weight reader complex, resolving the architectural basis of multivalent ADP-ribose recognition.","evidence":"X-ray crystallography, native mass spectrometry, KO-cell reconstitution with deletion mutants","pmids":["38511494"],"confidence":"High","gaps":["Full-length heterodimer structure remains unsolved","Oligomer regulation in cells is unknown"]},{"year":2024,"claim":"Identifying PARP14 as the major IFN-induced ADP-ribosyltransferase whose protein levels and activity are post-translationally regulated by the PARP9/DTX3L complex reframed DTX3L as a regulatory hub coordinating multiple PARP family members in interferon signaling.","evidence":"CRISPR KO, immunofluorescence of IFNγ-induced cytoplasmic inclusions, mass spectrometry, in vitro ADP-ribosylation assays with domain mutagenesis","pmids":["38834853","38182103"],"confidence":"High","gaps":["Mechanism by which DTX3L/PARP9 stabilizes PARP14 protein is unresolved","Whether DTX3L ubiquitylates PARP14 directly is not demonstrated"]},{"year":2024,"claim":"Discovering that DTX3L ubiquitylates single-stranded DNA and RNA at the 3ʹ-terminal adenosine via ester bonds—an activity shared only with DTX3 among Deltex members and reversible by USP2, JOSD1, and SARS-CoV-2 PLpro—revealed an unprecedented nucleic acid-modifying function for a ubiquitin ligase.","evidence":"In vitro ubiquitylation with NMR structural analysis of DTC-ssDNA interaction, domain deletion, deubiquitinase cleavage assay, parallel family-wide comparison","pmids":["39377462","39242775"],"confidence":"High","gaps":["Physiological role of nucleic acid ubiquitylation is completely unknown","Whether this occurs in cells or on specific transcripts/damage intermediates is untested"]},{"year":2024,"claim":"Showing that DTX3L ubiquitylates TIRR at K187 to promote its nuclear export and degradation, thereby displacing TIRR from 53BP1 and shifting DSB repair from NHEJ toward HR deficiency and PARP inhibitor sensitivity, defined a specific mechanism for DTX3L-mediated repair pathway regulation.","evidence":"Site-directed mutagenesis (K187), nuclear export inhibition, PARP inhibitor sensitivity assay, chromosomal instability analysis","pmids":["39632881"],"confidence":"High","gaps":["Whether TIRR ubiquitylation is PARP9-dependent is not addressed","Relevance across tumor types beyond the tested lines is unclear"]},{"year":2025,"claim":"Demonstrating reciprocal enzymatic regulation between DTX3L and USP28—DTX3L ubiquitylates USP28 for degradation while USP28 deubiquitylates both itself and DTX3L—showed that a DTX3L/DUB axis fine-tunes all four major DSB repair pathways.","evidence":"Reciprocal ubiquitylation/deubiquitylation assays, DSB repair pathway reporter assays with double knockdown rescue","pmids":["40703443"],"confidence":"High","gaps":["Whether this axis operates at damage sites or genome-wide is unknown","Upstream signals controlling the balance are not identified"]},{"year":2025,"claim":"Expanding the substrate repertoire in cancer contexts to include EGFR stabilization, SNAI1 degradation in EMT, SATB2 degradation in glioma stemness, LATS2 degradation in renal carcinoma, and PKCα degradation in breast cancer underscored DTX3L as a broadly relevant oncogenic or tumor-suppressive E3 ligase depending on context.","evidence":"Co-IP, ubiquitylation assays with site-directed mutagenesis, orthotopic/xenograft tumor models across multiple cancer types","pmids":["37460862","41972409","41507172","41203184","41679478"],"confidence":"Medium","gaps":["Context-dependent pro- vs. anti-tumorigenic roles are not mechanistically reconciled","Whether PARP9 participates in all cancer-associated substrate ubiquitylation events is unknown","Most substrates validated by single labs"]},{"year":null,"claim":"The physiological function of DTX3L-mediated nucleic acid ubiquitylation, the full structure of the oligomeric DTX3L-PARP9 complex, and the mechanism by which DTX3L chooses among its many protein substrates versus nucleic acid substrates in vivo remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No in vivo evidence for nucleic acid ubiquitylation","No full-length DTX3L-PARP9 structure","Substrate selectivity determinants unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,2,5,9,13,14,15,17,21,22,23,24,26,27,28,29]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0,2,5,13,14,15,21,22]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[21,22]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[21,22]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[2,5]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[9]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,3,8,13]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,8,19]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[2,3,7]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[2,3,7,13,23,24]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[5,11,14,17]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,9,12,15,26,27,28,29]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,14,25,29]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[15]}],"complexes":["PARP9-DTX3L heterodimer","DTX3L-PARP9-PARP14 ternary complex"],"partners":["PARP9","PARP14","STAT1","USP28","TIRR","TBK1","EGFR","SRC"],"other_free_text":[]},"mechanistic_narrative":"DTX3L is a RING-type E3 ubiquitin ligase of the Deltex family that functions as a central node integrating ubiquitin signaling, ADP-ribosylation, and nucleic acid modification in DNA damage repair, interferon responses, and cancer biology. DTX3L heterodimerizes with PARP9 via its D3 domain and homo-oligomerizes via D1/D2 domains to form a high-molecular-weight complex that ubiquitylates diverse protein substrates—including histone H4K91, p53, TIRR, TBK1, NLRP3, cGAS, SNAI1, SATB2, LATS2, PKCα, and USP28—targeting many for proteasomal degradation, while also catalyzing NAD⁺-dependent mono-ADP-ribosylation of ubiquitin Gly76 to restrain ubiquitylation, and reading PARP7-generated ADP-ribosylation marks on substrates such as the androgen receptor [PMID:12670957, PMID:28525742, PMID:35037691, PMID:37939374, PMID:38511494]. In the DNA damage response, DTX3L is recruited to PARylated damage sites via PARP9, where it monoubiquitylates H4K91 to facilitate 53BP1 recruitment, ubiquitylates TIRR to regulate NHEJ-to-HR pathway choice, degrades p53 at damage foci, and reciprocally regulates DSB repair through mutual antagonism with USP28 [PMID:19818714, PMID:23230272, PMID:37096048, PMID:39632881, PMID:40703443]. DTX3L also uniquely ubiquitylates single-stranded DNA and RNA at the 3ʹ-terminal adenosine via ester bond formation through its RING-DTC domains, an activity reversible by deubiquitinases and shared only with DTX3 among Deltex family members [PMID:39377462, PMID:39242775]."},"prefetch_data":{"uniprot":{"accession":"Q8TDB6","full_name":"E3 ubiquitin-protein ligase DTX3L","aliases":["B-lymphoma- and BAL-associated protein","Protein deltex-3-like","RING-type E3 ubiquitin transferase DTX3L","Rhysin-2","Rhysin2"],"length_aa":740,"mass_kda":83.6,"function":"E3 ubiquitin-protein ligase which, in association with ADP-ribosyltransferase PARP9, plays a role in DNA damage repair and in interferon-mediated antiviral responses (PubMed:12670957, PubMed:19818714, PubMed:23230272, PubMed:26479788). Monoubiquitinates several histones, including histone H2A, H2B, H3 and H4 (PubMed:28525742). In response to DNA damage, mediates monoubiquitination of 'Lys-91' of histone H4 (H4K91ub1) (PubMed:19818714). The exact role of H4K91ub1 in DNA damage response is still unclear but it may function as a licensing signal for additional histone H4 post-translational modifications such as H4 'Lys-20' methylation (H4K20me) (PubMed:19818714). PARP1-dependent PARP9-DTX3L-mediated ubiquitination promotes the rapid and specific recruitment of 53BP1/TP53BP1, UIMC1/RAP80, and BRCA1 to DNA damage sites (PubMed:23230272). By monoubiquitinating histone H2B H2BC9/H2BJ and thereby promoting chromatin remodeling, positively regulates STAT1-dependent interferon-stimulated gene transcription and thus STAT1-mediated control of viral replication (PubMed:26479788). Independently of its catalytic activity, promotes the sorting of chemokine receptor CXCR4 from early endosome to lysosome following CXCL12 stimulation by reducing E3 ligase ITCH activity and thus ITCH-mediated ubiquitination of endosomal sorting complex required for transport ESCRT-0 components HGS and STAM (PubMed:24790097). In addition, required for the recruitment of HGS and STAM to early endosomes (PubMed:24790097). In association with PARP9, plays a role in antiviral responses by mediating 'Lys-48'-linked ubiquitination of encephalomyocarditis virus (EMCV) and human rhinovirus (HRV) C3 proteases and thus promoting their proteasomal-mediated degradation (PubMed:26479788)","subcellular_location":"Cytoplasm; Nucleus; Early endosome membrane; Lysosome membrane","url":"https://www.uniprot.org/uniprotkb/Q8TDB6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DTX3L","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DTX3L","total_profiled":1310},"omim":[{"mim_id":"613143","title":"DELTEX E3 UBIQUITIN LIGASE 3L; DTX3L","url":"https://www.omim.org/entry/613143"},{"mim_id":"612065","title":"POLY(ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 9; PARP9","url":"https://www.omim.org/entry/612065"},{"mim_id":"603328","title":"MUSASHI RNA BINDING PROTEIN 1; MSI1","url":"https://www.omim.org/entry/603328"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DTX3L"},"hgnc":{"alias_symbol":["BBAP","RNF143"],"prev_symbol":[]},"alphafold":{"accession":"Q8TDB6","domains":[{"cath_id":"3.30.1370","chopping":"236-304","consensus_level":"medium","plddt":87.3562,"start":236,"end":304},{"cath_id":"3.30.1370,3.30.310","chopping":"378-445","consensus_level":"high","plddt":85.9872,"start":378,"end":445},{"cath_id":"3.30.390.130","chopping":"614-738","consensus_level":"high","plddt":94.8825,"start":614,"end":738},{"cath_id":"3.30.70","chopping":"12-88","consensus_level":"high","plddt":84.3149,"start":12,"end":88},{"cath_id":"3.30.70","chopping":"139-195","consensus_level":"high","plddt":82.8898,"start":139,"end":195},{"cath_id":"3.30.70","chopping":"307-363","consensus_level":"medium","plddt":86.1484,"start":307,"end":363},{"cath_id":"3.30.70","chopping":"451-509","consensus_level":"high","plddt":77.9663,"start":451,"end":509}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TDB6","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TDB6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TDB6-F1-predicted_aligned_error_v6.png","plddt_mean":76.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DTX3L","jax_strain_url":"https://www.jax.org/strain/search?query=DTX3L"},"sequence":{"accession":"Q8TDB6","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8TDB6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8TDB6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TDB6"}},"corpus_meta":[{"pmid":"26479788","id":"PMC_26479788","title":"PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection.","date":"2015","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26479788","citation_count":185,"is_preprint":false},{"pmid":"28525742","id":"PMC_28525742","title":"Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.","date":"2017","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/28525742","citation_count":173,"is_preprint":false},{"pmid":"19818714","id":"PMC_19818714","title":"BBAP monoubiquitylates histone H4 at lysine 91 and selectively modulates the DNA damage response.","date":"2009","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/19818714","citation_count":137,"is_preprint":false},{"pmid":"12670957","id":"PMC_12670957","title":"The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activity.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12670957","citation_count":125,"is_preprint":false},{"pmid":"16809771","id":"PMC_16809771","title":"BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16809771","citation_count":103,"is_preprint":false},{"pmid":"23230272","id":"PMC_23230272","title":"BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23230272","citation_count":97,"is_preprint":false},{"pmid":"24886089","id":"PMC_24886089","title":"DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells.","date":"2014","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24886089","citation_count":95,"is_preprint":false},{"pmid":"34358560","id":"PMC_34358560","title":"The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34358560","citation_count":92,"is_preprint":false},{"pmid":"26033450","id":"PMC_26033450","title":"Deltex-3-like (DTX3L) stimulates metastasis of melanoma through FAK/PI3K/AKT but not MEK/ERK pathway.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26033450","citation_count":49,"is_preprint":false},{"pmid":"38834853","id":"PMC_38834853","title":"PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation.","date":"2024","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/38834853","citation_count":36,"is_preprint":false},{"pmid":"25605023","id":"PMC_25605023","title":"HDAC1,2 inhibition impairs EZH2- and BBAP-mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25605023","citation_count":36,"is_preprint":false},{"pmid":"36706922","id":"PMC_36706922","title":"DTX3L induced NLRP3 ubiquitination inhibit R28 cell pyroptosis in OGD/R injury.","date":"2023","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/36706922","citation_count":31,"is_preprint":false},{"pmid":"35037691","id":"PMC_35037691","title":"Reconstitution of the DTX3L-PARP9 complex reveals determinants for high-affinity heterodimerization and multimeric assembly.","date":"2022","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/35037691","citation_count":28,"is_preprint":false},{"pmid":"28627634","id":"PMC_28627634","title":"DTX3L is upregulated in glioma and is associated with glioma progression.","date":"2017","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28627634","citation_count":25,"is_preprint":false},{"pmid":"38834852","id":"PMC_38834852","title":"PARP14 is regulated by the PARP9/DTX3L complex and promotes interferon γ-induced ADP-ribosylation.","date":"2024","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/38834852","citation_count":24,"is_preprint":false},{"pmid":"38182103","id":"PMC_38182103","title":"KH-like Domains in PARP9/DTX3L and PARP14 Coordinate Protein-Protein Interactions to Promote Cancer Cell Survival.","date":"2024","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/38182103","citation_count":23,"is_preprint":false},{"pmid":"36421918","id":"PMC_36421918","title":"Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer.","date":"2022","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/36421918","citation_count":20,"is_preprint":false},{"pmid":"39242775","id":"PMC_39242775","title":"Ubiquitylation of nucleic acids by DELTEX ubiquitin E3 ligase DTX3L.","date":"2024","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/39242775","citation_count":19,"is_preprint":false},{"pmid":"39696540","id":"PMC_39696540","title":"Spatial transcriptome profiling identifies DTX3L and BST2 as key biomarkers in esophageal squamous cell carcinoma tumorigenesis.","date":"2024","source":"Genome medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39696540","citation_count":19,"is_preprint":false},{"pmid":"39377462","id":"PMC_39377462","title":"DTX3L ubiquitin ligase ubiquitinates single-stranded nucleic acids.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/39377462","citation_count":18,"is_preprint":false},{"pmid":"35541235","id":"PMC_35541235","title":"Chemical activation of prolyl hydroxylase-2 by BBAP-1 down regulates hypoxia inducible factor-1α and fatty acid synthase for mammary gland chemoprevention.","date":"2018","source":"RSC advances","url":"https://pubmed.ncbi.nlm.nih.gov/35541235","citation_count":18,"is_preprint":false},{"pmid":"37096048","id":"PMC_37096048","title":"DTX3L E3 ligase targets p53 for degradation at poly ADP-ribose polymerase-associated DNA damage sites.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37096048","citation_count":17,"is_preprint":false},{"pmid":"38042777","id":"PMC_38042777","title":"Circular RNA circEYA3 promotes the radiation resistance of hepatocellular carcinoma via the IGF2BP2/DTX3L axis.","date":"2023","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/38042777","citation_count":16,"is_preprint":false},{"pmid":"36614304","id":"PMC_36614304","title":"Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36614304","citation_count":16,"is_preprint":false},{"pmid":"37255478","id":"PMC_37255478","title":"DTX3L Enhances Type I Interferon Antiviral Response by Promoting the Ubiquitination and Phosphorylation of TBK1.","date":"2023","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/37255478","citation_count":15,"is_preprint":false},{"pmid":"28653881","id":"PMC_28653881","title":"Effects of DTX3L on the cell proliferation, adhesion, and drug resistance of multiple myeloma cells.","date":"2017","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28653881","citation_count":14,"is_preprint":false},{"pmid":"37939374","id":"PMC_37939374","title":"Synthetic Dual Cysteine-ADP Ribosylated Peptides from the Androgen Receptor are Recognized by the DTX3L/PARP9 Complex.","date":"2023","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/37939374","citation_count":12,"is_preprint":false},{"pmid":"37460862","id":"PMC_37460862","title":"DTX3L Accelerates Pancreatic cancer Progression via FAK/PI3K/AKT Axis.","date":"2023","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37460862","citation_count":12,"is_preprint":false},{"pmid":"37774567","id":"PMC_37774567","title":"DTX3L mediated ubiquitination of cGAS suppresses antitumor immunity in pancreatic cancer.","date":"2023","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/37774567","citation_count":10,"is_preprint":false},{"pmid":"38511494","id":"PMC_38511494","title":"Oligomerization mediated by the D2 domain of DTX3L is critical for DTX3L-PARP9 reading function of mono-ADP-ribosylated androgen receptor.","date":"2024","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/38511494","citation_count":7,"is_preprint":false},{"pmid":"39632881","id":"PMC_39632881","title":"DTX3L-mediated TIRR nuclear export and degradation regulates DNA repair pathway choice and PARP inhibitor sensitivity.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39632881","citation_count":6,"is_preprint":false},{"pmid":"27922665","id":"PMC_27922665","title":"Translocation of BBAP from the cytoplasm to the nucleus reduces the metastatic ability of vemurafenib-resistant SKMEL28 cells.","date":"2016","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/27922665","citation_count":5,"is_preprint":false},{"pmid":"40695431","id":"PMC_40695431","title":"DTX3L E3 ligase: Molecular functions, regulatory mechanisms, and potential as a novel cancer biomarker and therapeutic target.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40695431","citation_count":3,"is_preprint":false},{"pmid":"40194649","id":"PMC_40194649","title":"Small extracellular vesicles from adipose derived stem cells alleviate microglia activation and improve motor deficit of Parkinson's disease via miR-100-5p/DTX3L/STAT1 signaling axis.","date":"2025","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/40194649","citation_count":3,"is_preprint":false},{"pmid":"32473705","id":"PMC_32473705","title":"DTX3L/ARTD9 contributes to inflammation of fibroblast-like synoviocytes by increasing STAT1 translocation.","date":"2020","source":"Tissue & cell","url":"https://pubmed.ncbi.nlm.nih.gov/32473705","citation_count":3,"is_preprint":false},{"pmid":"38076829","id":"PMC_38076829","title":"Oligomerisation mediated by the D2 domain of DTX3L is critical for DTX3L-PARP9 reading function of mono-ADP-ribosylated androgen receptor.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38076829","citation_count":2,"is_preprint":false},{"pmid":"40703443","id":"PMC_40703443","title":"The E3 ubiquitin ligase DTX3L and the deubiquitinase USP28 fine-tune DNA repair through mutual regulation of their protein levels.","date":"2025","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/40703443","citation_count":2,"is_preprint":false},{"pmid":"37579950","id":"PMC_37579950","title":"Discovery of DTX3L inhibitors through a homogeneous FRET-based assay that monitors formation and removal of poly-ubiquitin chains.","date":"2023","source":"SLAS discovery : advancing life sciences R & D","url":"https://pubmed.ncbi.nlm.nih.gov/37579950","citation_count":1,"is_preprint":false},{"pmid":"39055911","id":"PMC_39055911","title":"Erratum: DTX3L E3 ligase targets p53 for degradation at poly ADP-ribose polymerase-associated DNA damage sites.","date":"2024","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/39055911","citation_count":1,"is_preprint":false},{"pmid":"41507172","id":"PMC_41507172","title":"USP10 promotes glioma stem cell maintenance and glioblastoma growth by antagonizing DTX3L-mediated SATB2 ubiquitination.","date":"2026","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/41507172","citation_count":0,"is_preprint":false},{"pmid":"41203184","id":"PMC_41203184","title":"DTX3L promotes renal cell carcinoma progression via ubiquitination and degradation of LATS2.","date":"2025","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/41203184","citation_count":0,"is_preprint":false},{"pmid":"41883974","id":"PMC_41883974","title":"Investigating the functions and molecular mechanisms of DTX3L in cancer progression.","date":"2026","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41883974","citation_count":0,"is_preprint":false},{"pmid":"41679478","id":"PMC_41679478","title":"E3 ubiquitin ligase DTX3L promotes breast cancer progression by enhancing PKCα ubiquitination and inhibiting the p38 MAPK signaling pathway.","date":"2026","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/41679478","citation_count":0,"is_preprint":false},{"pmid":"41882821","id":"PMC_41882821","title":"Role of the H19/miR-423-5p/DTX3L Axis in Enhancing the Malignant Phenotype of Nasopharyngeal Carcinoma Cells.","date":"2026","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/41882821","citation_count":0,"is_preprint":false},{"pmid":"41972409","id":"PMC_41972409","title":"DTX3L Inhibits the EMT, Metastasis, and Stem-Like Features of Gastric Cancer Through Promoting GSK-3β Dependent SNAI1 Decay.","date":"2026","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41972409","citation_count":0,"is_preprint":false},{"pmid":"41684454","id":"PMC_41684454","title":"LINC00973/DTX3L Axis Promotes Non-Small Cell Lung Cancer Progression and Serves as a Therapeutic Target.","date":"2026","source":"Smart medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41684454","citation_count":0,"is_preprint":false},{"pmid":"41930575","id":"PMC_41930575","title":"[Expression of Concern] DTX3L is upregulated in glioma and is associated with glioma progression.","date":"2026","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41930575","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.09.30.25337006","title":"DNA Methylation Profiling in Childhood-Onset Lupus Reveals Distinct Epigenetic Clusters and Suggests Epigenetic Drivers of Disease Activity","date":"2025-10-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.30.25337006","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.18.602927","title":"Characterizing the Spatial Distribution of Dendritic RNA at Single Molecule Resolution","date":"2024-07-19","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.18.602927","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":24232,"output_tokens":6682,"usd":0.086463},"stage2":{"model":"claude-opus-4-6","input_tokens":10385,"output_tokens":4515,"usd":0.2472},"total_usd":0.333663,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"DTX3L (BBAP) functions as an E3 ubiquitin ligase, demonstrated by self-ubiquitination activity; DTX family members homodimerize and heterodimerize in vivo, with BBAP and DTX1 associating via their unique N termini to enhance self-ubiquitination.\",\n      \"method\": \"In vitro self-ubiquitination assay, co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro E3 ligase assay with mutagenesis context, replicated in subsequent studies\",\n      \"pmids\": [\"12670957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BBAP (DTX3L) regulates the subcellular localization of BAL1 (PARP9) through a dynamic shuttling mechanism, and both are regulated by a IFN-γ-responsive bidirectional promoter on chromosome 3q21.\",\n      \"method\": \"Immunofluorescence localization, reporter assay, co-expression studies\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct localization experiment with functional consequence, single lab\",\n      \"pmids\": [\"16809771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"BBAP (DTX3L) selectively monoubiquitylates histone H4 at lysine 91, and disruption of this activity is associated with loss of chromatin-associated H4K20 methylase, reduction in mono- and dimethyl H4K20, and delayed 53BP1 foci formation at DNA damage sites.\",\n      \"method\": \"In vitro ubiquitylation assay, site-directed mutagenesis, immunofluorescence of 53BP1 foci\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro assay with mutagenesis, multiple orthogonal readouts, replicated by other labs\",\n      \"pmids\": [\"19818714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"BAL1 (PARP9) is recruited to PARP1-PARylated DNA damage sites via its macrodomains in a PAR-dependent manner, and its partner DTX3L (BBAP) mediates local ubiquitylation that promotes subsequent BRCA1 and 53BP1 recruitment, functioning independently of ATM, MDC1, and RNF8.\",\n      \"method\": \"Genetic epistasis (ATM/MDC1/RNF8 knockouts), live-cell imaging, co-immunoprecipitation, PAR-binding assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — epistasis with multiple DDR pathway components, reconstitution of recruitment, multiple orthogonal methods\",\n      \"pmids\": [\"23230272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DTX3L forms a complex with ARTD8 (PARP14) and ARTD9 (PARP9), and together these complexes repress IRF1 expression; DTX3L together with STAT1 and STAT3 mediates cell migration; ARTD8 enzymatic activity is required for survival in metastatic prostate cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown with proliferation/survival/migration assays, Western blot\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — reciprocal Co-IP with functional KD phenotype, single lab\",\n      \"pmids\": [\"24886089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PARP9-DTX3L complex interacts with STAT1 and acts as an E3 ubiquitin ligase targeting host histone H2BJ to promote interferon-stimulated gene expression, and also targets viral 3C proteases for degradation via the immunoproteasome.\",\n      \"method\": \"Co-immunoprecipitation, transgenic mouse model, ubiquitin ligase assay, antiviral infection assay\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo and in vitro mechanistic validation with multiple substrates, replicated by other labs\",\n      \"pmids\": [\"26479788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DTX3L depletion in melanoma cells decreases FAK/PI3K/AKT signaling activity but not MEK/ERK signaling, and reduces invasion and metastasis, establishing FAK/PI3K/AKT as the pathway through which DTX3L mediates melanoma metastasis.\",\n      \"method\": \"siRNA knockdown, invasion/metastasis assays, Western blot of signaling intermediates\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — KD with defined pathway readout, single lab\",\n      \"pmids\": [\"26033450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HDAC1,2 inhibition increases H4K91 acetylation, which competitively reduces BBAP (DTX3L)-mediated H4K91 monoubiquitination and impairs BBAP-dependent DSB repair.\",\n      \"method\": \"Small molecule inhibition, histone modification ChIP/Western blot, DSB repair assay\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic link between competing PTMs on H4K91 and repair, single lab\",\n      \"pmids\": [\"25605023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BBAP (DTX3L) translocates from the cytoplasm to the nucleus upon paclitaxel treatment in vemurafenib-resistant melanoma cells, and this translocation decreases metastatic ability via downregulation of phospho-FAK and N-cadherin and upregulation of p21 and E-cadherin.\",\n      \"method\": \"Immunofluorescence, subcellular fractionation, invasion/migration assays\",\n      \"journal\": \"Molecular medicine reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — localization experiment with phenotypic consequence but limited mechanistic follow-up, single lab\",\n      \"pmids\": [\"27922665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DTX3L (PARP9/Dtx3L heterodimer) mediates NAD+-dependent mono-ADP-ribosylation of the carboxyl group of ubiquitin Gly76, exclusively in the context of ubiquitin processing by E1 and E2 enzymes; this ADP-ribosylation precludes substrate ubiquitylation. Poly(ADP-ribose) binding to PARP9 macrodomains increases E3 activity, while NAD+ restrains it.\",\n      \"method\": \"In vitro ADP-ribosylation assay, mutagenesis of NAD+ binding site, mass spectrometry, biochemical reconstitution\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis, mass spectrometry validation, multiple orthogonal methods\",\n      \"pmids\": [\"28525742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DTX3L and ARTD9 (PARP9) associate with STAT1 under TNF-α stimulation in fibroblast-like synoviocytes and modulate STAT1 nuclear localization and transcriptional activity, promoting expression of MMP-9 and IL-6.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence, siRNA knockdown, Western blot\",\n      \"journal\": \"Tissue & cell\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP with localization data, single lab, limited mechanistic depth\",\n      \"pmids\": [\"32473705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"IFN signaling induces PARP9/DTX3L-dependent ADP-ribosylation of host proteins, and the SARS-CoV-2 Nsp3 macrodomain reverses this modification; however, deletion of PARP9 or DTX3L does not impair IFN signaling or induction of IFN-responsive genes, indicating ADP-ribosylation is a downstream effector rather than a signaling regulator.\",\n      \"method\": \"Immunofluorescence-based ADP-ribosylation assay, CRISPR knockout of PARP9/DTX3L, ectopic Nsp3 expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic KO with multiple functional readouts, replicated in parallel study\",\n      \"pmids\": [\"34358560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The DTX3L D3 domain (residues 230-510) mediates interaction with PARP9 with nanomolar affinity and 1:1 stoichiometry; the N-terminal region (1-200) mediates higher-order oligomerization; ADP-ribosylation of ubiquitin Gly76 is reversible in vitro by macrodomain-type hydrolases.\",\n      \"method\": \"Recombinant protein reconstitution, binding affinity measurement, size-exclusion chromatography, in vitro deribosylation assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with domain mapping, quantitative binding measurements, multiple orthogonal approaches\",\n      \"pmids\": [\"35037691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DTX3L rapidly co-localizes with p53 at PARP1-PARylated DNA damage sites, polyubiquitylates p53 on its lysine-rich C-terminal domain, and targets p53 for proteasomal degradation; DTX3L knockout significantly increases and prolongs p53 retention at damage sites.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitylation assay, live-cell imaging, CRISPR knockout\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — KO with direct substrate ubiquitylation demonstrated and spatial-temporal imaging\",\n      \"pmids\": [\"37096048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DTX3L ubiquitinates TBK1 at K30 and K401 via K63-linked ubiquitination, and binds SRC tyrosine kinase to mediate TBK1 phosphorylation, establishing an IFN-β-ETS1-DTX3L-TBK1 positive-feedback loop.\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis of ubiquitination sites, kinase phosphorylation assay\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis of substrate sites with functional readout, single lab\",\n      \"pmids\": [\"37255478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DTX3L ubiquitinates NLRP3 via interaction between the NLRP3 LRR domain and the DTX3L RING domain, resulting in NLRP3 degradation and regulation of pyroptosis.\",\n      \"method\": \"Co-immunoprecipitation, mass spectrometry, domain mapping, ubiquitylation assay, LDH/cell death assays\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — domain-level interaction mapping with functional pyroptosis readout, single lab\",\n      \"pmids\": [\"36706922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Dual ADP-ribosylation of closely spaced cysteines on the androgen receptor (AR) by PARP7 mediates recognition by the DTX3L/PARP9 complex with high affinity (Kd = 80.5 nM); oligomerization of the DTX3L/PARP9 complex is required for efficient ADP-ribosyl-peptide interaction.\",\n      \"method\": \"Synthetic peptide binding assay, fluorescence-based affinity measurement, deletion mutagenesis of oligomerization domain\",\n      \"journal\": \"ACS chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative binding with synthetic substrates and mutagenesis, multiple orthogonal methods\",\n      \"pmids\": [\"37939374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DTX3L mediates ubiquitination and degradation of cGAS in pancreatic cancer cells, suppressing cGAS-STING pathway activation and antitumor immunity.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitylation assay, siRNA knockdown with STING pathway readout\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — substrate ubiquitylation with pathway functional consequence, single lab\",\n      \"pmids\": [\"37774567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Crystal structure of the DTX3L N-terminal D2 domain reveals a tetramer with D2 symmetry and two interfaces; D1-D2 domains mediate homo-oligomerization and are dispensable for PARP9 heterodimerization but required for assembling the high-molecular-weight oligomeric complex with efficient reader function for ADP-ribosylated androgen receptor.\",\n      \"method\": \"X-ray crystallography, native mass spectrometry, DTX3L-KO cell reconstitution with deletion mutants, ADP-ribose reader assay\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional validation by mutagenesis and cell reconstitution\",\n      \"pmids\": [\"38511494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PARP14 is the major enzyme responsible for IFN-induced ADP-ribosylation; PARP9/DTX3L complex regulates PARP14 protein levels post-translationally and both localize to IFNγ-induced cytoplasmic inclusions; PARP14 ADP-ribosylates itself and DTX3L; PARP9 macrodomain 1 hydrolyzes PARP14 activity product.\",\n      \"method\": \"CRISPR knockout, immunofluorescence, mass spectrometry, in vitro ADP-ribosylation assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic KO with multiple orthogonal methods, parallel replication in companion paper\",\n      \"pmids\": [\"38834853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PARP9/DTX3L complex is required to uphold PARP14 protein levels via post-translational mechanisms; KH-like domains in PARP9, DTX3L, and PARP14 coordinate protein-protein interactions; DTX3L interaction with PARP14 in vitro suppresses PARP14 auto-ADP-ribosylation and promotes trans-ADP-ribosylation of PARP9 and DTX3L; DTX3L homodimerization is coordinated by a KH-like domain.\",\n      \"method\": \"In vitro ADP-ribosylation assay, domain mutagenesis, co-immunoprecipitation, cell survival assay with truncation mutants\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro assay with domain mutagenesis plus cellular rescue experiments, companion study replication\",\n      \"pmids\": [\"38182103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DTX3L ubiquitylates single-stranded DNA and RNA (and double-stranded DNA with ≥2 nt 3' overhang) via ester bond formation at the 3'-terminal adenosine; the minimal catalytic fragment comprises the C-terminal RING and DTC domains; NMR analysis shows the DTC domain binds single-stranded DNA and facilitates Ub transfer from RING-bound E2-conjugated Ub; this modification is reversibly cleaved by deubiquitinases including USP2, JOSD1, and SARS-CoV-2 PLpro.\",\n      \"method\": \"In vitro ubiquitylation assay, NMR, domain deletion mutagenesis, deubiquitinase cleavage assay\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with NMR structural validation and mutagenesis, multiple DUBs tested\",\n      \"pmids\": [\"39377462\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DTX3L ubiquitylates DNA and RNA in vitro via ester bond formation; this activity is shared with DTX3 but not DTX1, DTX2, or DTX4; DTX3L shows preference for 3'-terminal adenosine; ubiquitylation of nucleic acids is reversible by USP2, JOSD1, and SARS-CoV-2 PLpro.\",\n      \"method\": \"In vitro ubiquitylation assay with purified proteins and synthetic substrates, parallel testing of all DELTEX family members\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with substrate specificity mapping across family members, replicated in parallel study\",\n      \"pmids\": [\"39242775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DTX3L ubiquitinates TIRR at lysine 187, facilitating XPO1-mediated TIRR nuclear export and proteasomal degradation after DNA damage; this displaces TIRR from 53BP1, impairing NHEJ and causing HR deficiency and PARP inhibitor sensitivity.\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis (K187), nuclear export inhibition, PARP inhibitor sensitivity assay, chromosomal instability assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — specific ubiquitylation site identified with mutagenesis, functional consequence in multiple assays, clinical correlation\",\n      \"pmids\": [\"39632881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DTX3L ubiquitinates USP28, leading to its proteasomal degradation, while USP28 counteracts by deubiquitinating both itself and DTX3L; this mutual regulation fine-tunes DSB repair across NHEJ, HR, SSA, and MMEJ pathways.\",\n      \"method\": \"Ubiquitylation assay, deubiquitylation assay, DSB repair pathway reporter assays, double knockdown rescue\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal enzymatic activities demonstrated in vitro with functional rescue in multiple repair pathways\",\n      \"pmids\": [\"40703443\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DTX3L binds EGFR and prevents its ubiquitination-mediated degradation, thereby activating the FAK/PI3K/Akt pathway to promote pancreatic cancer progression.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitylation assay, orthotopic tumor model, proliferation/invasion assays\",\n      \"journal\": \"Biochemical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP with substrate ubiquitylation and in vivo tumor model, single lab\",\n      \"pmids\": [\"37460862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"DTX3L directly interacts with and ubiquitinates SNAI1 (SNAIL), a master EMT regulator, leading to GSK-3β-dependent proteasomal degradation of SNAI1; loss of DTX3L stabilizes SNAI1 and enhances EMT and stem-like phenotypes in gastric cancer.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitylation assay, cell line/organoid/animal model, TGF-β1/miR-135b-5p regulatory axis characterization\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — substrate ubiquitylation shown with multiple model systems, single lab\",\n      \"pmids\": [\"41972409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"USP10 and DTX3L regulate SATB2 ubiquitination at K266 in glioma stem cells through mutually exclusive interactions and opposing activities; DTX3L acts as a ubiquitin ligase for SATB2, promoting its degradation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitylation assay, site-directed mutagenesis (K266), GSC self-renewal assay, in vivo tumor model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — specific ubiquitylation site identified with mutagenesis, functional rescue, single lab\",\n      \"pmids\": [\"41507172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"DTX3L binds PKCα through its RING domain and targets PKCα for K48-linked ubiquitination and proteasomal degradation, attenuating p38 MAPK phosphorylation to drive breast cancer progression.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, ubiquitylation assay, transcriptomics after KD, kinase phosphorylation assay\",\n      \"journal\": \"International journal of biological macromolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — domain-level interaction with K48-linkage specificity and pathway functional readout, single lab\",\n      \"pmids\": [\"41679478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DTX3L promotes renal cell carcinoma progression by ubiquitinating and degrading the Hippo pathway tumor suppressor LATS2.\",\n      \"method\": \"Proteomic screening, co-immunoprecipitation, ubiquitylation assay, in vitro and in vivo tumor growth assays\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — substrate identified by proteomics and validated by Co-IP/ubiquitylation with in vivo model, single lab\",\n      \"pmids\": [\"41203184\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DTX3L is a multi-domain RING-type E3 ubiquitin ligase that heterodimerizes with PARP9 (via its D3 domain) and homo-oligomerizes (via D1/D2 domains) to form a complex with dual enzymatic activities: it ubiquitylates protein substrates (including histone H4K91, p53, TIRR, TBK1, NLRP3, cGAS, SNAI1, SATB2, LATS2, PKCα, and USP28) and, together with PARP9, mediates NAD+-dependent mono-ADP-ribosylation of ubiquitin Gly76 to restrain ubiquitylation; the complex also reads PARP7-generated ADP-ribosylation marks on substrates such as the androgen receptor, regulates PARP14 protein levels and activity through protein-protein interaction, and uniquely ubiquitylates single-stranded DNA and RNA via its RING-DTC domains, with all these activities critically linked to interferon signaling, DNA damage response pathway choice, and cancer progression.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DTX3L is a RING-type E3 ubiquitin ligase of the Deltex family that functions as a central node integrating ubiquitin signaling, ADP-ribosylation, and nucleic acid modification in DNA damage repair, interferon responses, and cancer biology. DTX3L heterodimerizes with PARP9 via its D3 domain and homo-oligomerizes via D1/D2 domains to form a high-molecular-weight complex that ubiquitylates diverse protein substrates—including histone H4K91, p53, TIRR, TBK1, NLRP3, cGAS, SNAI1, SATB2, LATS2, PKCα, and USP28—targeting many for proteasomal degradation, while also catalyzing NAD⁺-dependent mono-ADP-ribosylation of ubiquitin Gly76 to restrain ubiquitylation, and reading PARP7-generated ADP-ribosylation marks on substrates such as the androgen receptor [PMID:12670957, PMID:28525742, PMID:35037691, PMID:37939374, PMID:38511494]. In the DNA damage response, DTX3L is recruited to PARylated damage sites via PARP9, where it monoubiquitylates H4K91 to facilitate 53BP1 recruitment, ubiquitylates TIRR to regulate NHEJ-to-HR pathway choice, degrades p53 at damage foci, and reciprocally regulates DSB repair through mutual antagonism with USP28 [PMID:19818714, PMID:23230272, PMID:37096048, PMID:39632881, PMID:40703443]. DTX3L also uniquely ubiquitylates single-stranded DNA and RNA at the 3ʹ-terminal adenosine via ester bond formation through its RING-DTC domains, an activity reversible by deubiquitinases and shared only with DTX3 among Deltex family members [PMID:39377462, PMID:39242775].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing that DTX3L possesses intrinsic E3 ubiquitin ligase activity and that Deltex family members homo- and heterodimerize resolved the basic enzymatic identity of this previously uncharacterized protein.\",\n      \"evidence\": \"In vitro self-ubiquitination assay and co-immunoprecipitation of DTX family members\",\n      \"pmids\": [\"12670957\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No physiological substrate identified\", \"Dimerization interface unmapped\", \"No cellular function established\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating that DTX3L and PARP9 are co-regulated by an IFN-γ-responsive bidirectional promoter and that DTX3L controls PARP9 subcellular localization linked the E3 ligase to interferon biology and established the obligate functional partnership.\",\n      \"evidence\": \"Immunofluorescence, reporter assays, and co-expression studies\",\n      \"pmids\": [\"16809771\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether DTX3L directly binds PARP9 was not demonstrated biochemically\", \"Functional consequence of relocalization unclear\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identification of histone H4K91 as the first physiological substrate connected DTX3L to chromatin biology and the DNA damage response, showing that H4K91 monoubiquitylation supports H4K20 methylation and 53BP1 focus formation.\",\n      \"evidence\": \"In vitro ubiquitylation assay with site-directed mutagenesis and 53BP1 foci immunofluorescence\",\n      \"pmids\": [\"19818714\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether H4K91ub is direct trigger or permissive mark for H4K20me was unresolved\", \"Competition with H4K91 acetylation not yet tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showing that PARP9 recruits DTX3L to PARylated DNA damage sites independently of ATM/MDC1/RNF8 established a parallel ubiquitin-dependent DDR pathway that promotes BRCA1 and 53BP1 recruitment.\",\n      \"evidence\": \"Genetic epistasis in ATM/MDC1/RNF8 knockouts with live-cell imaging and PAR-binding assays\",\n      \"pmids\": [\"23230272\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrates ubiquitylated at damage sites beyond H4 were unknown\", \"Relative contribution to repair pathway choice unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Expanding DTX3L substrates to include host histone H2BJ and viral 3C proteases, and showing STAT1-dependent ISG regulation, established the PARP9-DTX3L complex as a bona fide innate immune effector targeting both host chromatin and viral proteins for degradation.\",\n      \"evidence\": \"Co-immunoprecipitation, ubiquitin ligase assay, transgenic mouse model, antiviral infection assay\",\n      \"pmids\": [\"26479788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Breadth of viral substrates unknown\", \"Whether ubiquitylation is K48- or K63-linked on these substrates was not specified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Linking DTX3L to FAK/PI3K/AKT signaling in melanoma invasion and showing that acetylation at H4K91 competes with DTX3L-mediated ubiquitylation extended the functional scope to cancer metastasis and PTM crosstalk.\",\n      \"evidence\": \"siRNA knockdown with signaling readouts in melanoma; HDAC inhibitor treatment with DSB repair assays\",\n      \"pmids\": [\"26033450\", \"25605023\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ubiquitylation targets in FAK pathway not identified\", \"Whether H4K91 PTM competition occurs genome-wide or at damage sites specifically was unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Discovering that the PARP9-DTX3L complex mono-ADP-ribosylates ubiquitin at Gly76 in an NAD⁺-dependent manner—precluding substrate ubiquitylation—revealed a fundamentally new enzymatic activity coupling ADP-ribosylation to ubiquitin regulation.\",\n      \"evidence\": \"In vitro reconstitution with mass spectrometry, mutagenesis of NAD⁺ binding site\",\n      \"pmids\": [\"28525742\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which active site catalyzes the ADP-ribosylation was debated\", \"In vivo substrates of ADPr-Ub not identified\", \"Reversibility mechanism unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Mapping the D3 domain as the nanomolar-affinity PARP9-binding interface and showing that N-terminal D1/D2 domains drive oligomerization, while demonstrating reversibility of Ub-Gly76 ADP-ribosylation by macrodomain hydrolases, provided the structural logic for the complex.\",\n      \"evidence\": \"Recombinant reconstitution, quantitative binding measurements, size-exclusion chromatography, in vitro deribosylation\",\n      \"pmids\": [\"35037691\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of the full heterodimer\", \"Oligomerization stoichiometry in cells uncertain\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identifying p53, TBK1, NLRP3, and cGAS as DTX3L ubiquitylation substrates broadened the functional repertoire to encompass tumor suppressor turnover at damage sites, innate immune signaling via TBK1-IFN-β positive feedback, inflammasome regulation, and cGAS-STING suppression in cancer.\",\n      \"evidence\": \"Co-IP, site-directed mutagenesis of ubiquitylation sites, CRISPR KO with live-cell imaging (p53); ubiquitylation assays with pathway readouts (TBK1, NLRP3, cGAS)\",\n      \"pmids\": [\"37096048\", \"37255478\", \"36706922\", \"37774567\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether all substrates require PARP9 co-factor is unclear\", \"Linkage type specificity for each substrate incompletely characterized\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrating that PARP7-mediated dual ADP-ribosylation of closely spaced cysteines on the androgen receptor is read by the oligomeric DTX3L/PARP9 complex with nanomolar affinity established a 'writer-reader' paradigm for ADP-ribosylation signaling.\",\n      \"evidence\": \"Synthetic ADP-ribosylated peptide binding assay, fluorescence affinity measurement, oligomerization domain deletion mutagenesis\",\n      \"pmids\": [\"37939374\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream functional consequence of AR reading is unknown\", \"Whether other ADP-ribosylated substrates are similarly read is untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Crystal structure of the D2 domain tetramer and functional reconstitution showed that D1-D2-mediated oligomerization is dispensable for PARP9 binding but essential for assembling the high-molecular-weight reader complex, resolving the architectural basis of multivalent ADP-ribose recognition.\",\n      \"evidence\": \"X-ray crystallography, native mass spectrometry, KO-cell reconstitution with deletion mutants\",\n      \"pmids\": [\"38511494\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length heterodimer structure remains unsolved\", \"Oligomer regulation in cells is unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identifying PARP14 as the major IFN-induced ADP-ribosyltransferase whose protein levels and activity are post-translationally regulated by the PARP9/DTX3L complex reframed DTX3L as a regulatory hub coordinating multiple PARP family members in interferon signaling.\",\n      \"evidence\": \"CRISPR KO, immunofluorescence of IFNγ-induced cytoplasmic inclusions, mass spectrometry, in vitro ADP-ribosylation assays with domain mutagenesis\",\n      \"pmids\": [\"38834853\", \"38182103\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which DTX3L/PARP9 stabilizes PARP14 protein is unresolved\", \"Whether DTX3L ubiquitylates PARP14 directly is not demonstrated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovering that DTX3L ubiquitylates single-stranded DNA and RNA at the 3ʹ-terminal adenosine via ester bonds—an activity shared only with DTX3 among Deltex members and reversible by USP2, JOSD1, and SARS-CoV-2 PLpro—revealed an unprecedented nucleic acid-modifying function for a ubiquitin ligase.\",\n      \"evidence\": \"In vitro ubiquitylation with NMR structural analysis of DTC-ssDNA interaction, domain deletion, deubiquitinase cleavage assay, parallel family-wide comparison\",\n      \"pmids\": [\"39377462\", \"39242775\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological role of nucleic acid ubiquitylation is completely unknown\", \"Whether this occurs in cells or on specific transcripts/damage intermediates is untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showing that DTX3L ubiquitylates TIRR at K187 to promote its nuclear export and degradation, thereby displacing TIRR from 53BP1 and shifting DSB repair from NHEJ toward HR deficiency and PARP inhibitor sensitivity, defined a specific mechanism for DTX3L-mediated repair pathway regulation.\",\n      \"evidence\": \"Site-directed mutagenesis (K187), nuclear export inhibition, PARP inhibitor sensitivity assay, chromosomal instability analysis\",\n      \"pmids\": [\"39632881\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TIRR ubiquitylation is PARP9-dependent is not addressed\", \"Relevance across tumor types beyond the tested lines is unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstrating reciprocal enzymatic regulation between DTX3L and USP28—DTX3L ubiquitylates USP28 for degradation while USP28 deubiquitylates both itself and DTX3L—showed that a DTX3L/DUB axis fine-tunes all four major DSB repair pathways.\",\n      \"evidence\": \"Reciprocal ubiquitylation/deubiquitylation assays, DSB repair pathway reporter assays with double knockdown rescue\",\n      \"pmids\": [\"40703443\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this axis operates at damage sites or genome-wide is unknown\", \"Upstream signals controlling the balance are not identified\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Expanding the substrate repertoire in cancer contexts to include EGFR stabilization, SNAI1 degradation in EMT, SATB2 degradation in glioma stemness, LATS2 degradation in renal carcinoma, and PKCα degradation in breast cancer underscored DTX3L as a broadly relevant oncogenic or tumor-suppressive E3 ligase depending on context.\",\n      \"evidence\": \"Co-IP, ubiquitylation assays with site-directed mutagenesis, orthotopic/xenograft tumor models across multiple cancer types\",\n      \"pmids\": [\"37460862\", \"41972409\", \"41507172\", \"41203184\", \"41679478\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Context-dependent pro- vs. anti-tumorigenic roles are not mechanistically reconciled\", \"Whether PARP9 participates in all cancer-associated substrate ubiquitylation events is unknown\", \"Most substrates validated by single labs\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The physiological function of DTX3L-mediated nucleic acid ubiquitylation, the full structure of the oligomeric DTX3L-PARP9 complex, and the mechanism by which DTX3L chooses among its many protein substrates versus nucleic acid substrates in vivo remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No in vivo evidence for nucleic acid ubiquitylation\", \"No full-length DTX3L-PARP9 structure\", \"Substrate selectivity determinants unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 2, 5, 9, 13, 14, 15, 17, 21, 22, 23, 24, 26, 27, 28, 29]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0, 2, 5, 13, 14, 15, 21, 22]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [21, 22]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [21, 22]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [2, 5]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 3, 8, 13]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 8, 19]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [2, 3, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [2, 3, 7, 13, 23, 24]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [5, 11, 14, 17]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 9, 12, 15, 26, 27, 28, 29]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 14, 25, 29]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [15]}\n    ],\n    \"complexes\": [\n      \"PARP9-DTX3L heterodimer\",\n      \"DTX3L-PARP9-PARP14 ternary complex\"\n    ],\n    \"partners\": [\n      \"PARP9\",\n      \"PARP14\",\n      \"STAT1\",\n      \"USP28\",\n      \"TIRR\",\n      \"TBK1\",\n      \"EGFR\",\n      \"SRC\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}